Citation Impact
Citing Papers
MHC-Restricted Cytotoxic T Cells: Studies on the Biological Role of Polymorphic Major Transplantation Antigens Determining T-Cell Restriction-Specificity, Function, and Responsiveness
1979 StandoutNobel
Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines.
1988
Contrasting Properties of Hypoxia-Inducible Factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-Associated Renal Cell Carcinoma
2005 StandoutNobel
Hypoxia — a key regulatory factor in tumour growth
2002 Standout
Pattern of nucleotide substitution at major histocompatibility complex class I loci reveals overdominant selection
1988 StandoutNature
The cultural mouse
2001 StandoutNobel
S. cerevisiae α pheromone receptors activate a novel signal transduction pathway for mating partner discrimination
1991 StandoutNobel
Inducible Nitric-oxide Synthase and Nitric Oxide Production in Human Fetal Astrocytes and Microglia
1997 StandoutNobel
The p53 proto-oncogene can act as a suppressor of transformation
1989 Standout
Role of Transforming Growth Factor β in Human Disease
2000 Standout
Ido expression by dendritic cells: tolerance and tryptophan catabolism
2004 Standout
In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density
2001
Crop Production under Drought and Heat Stress: Plant Responses and Management Options
2017 Standout
A guide to immunometabolism for immunologists
2016 Standout
O-GlcNAc-Specific Antibody CTD110.6 Cross-Reacts with N-GlcNAc2-Modified Proteins Induced under Glucose Deprivation
2011
TGF-β signaling in tumor suppression and cancer progression
2001 Standout
Proteins of the intermediate filament cytoskeleton as markers for astrocytes and human astrocytomas
1994
The resurgence of platinum-based cancer chemotherapy
2007 Standout
Site‐directed antibodies to tubulin
1993
Selection of large diversities of antiidiotypic antibody fragments by phage display
2002 StandoutNobel
Rapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacy1
2002
Skin Cancers after Organ Transplantation
2003 Standout
Expression of MaTu‐MN protein in human tumor cultures and in clinical specimens
1993
Epithelial–mesenchymal transitions in tumour progression
2002 Standout
Forty years with homologous recombination
2001 StandoutNobel
Cellular processing of platinum anticancer drugs
2005 Standout
Murine Coronavirus Spike Glycoprotein Mediates Degree of Viral Spread, Inflammation, and Virus-Induced Immunopathology in the Central Nervous System
2002
Human-tumor-derived cell lines contain common and different transforming genes
1981
Structure of the αβ tubulin dimer by electron crystallography
1998 StandoutNature
High sensitive approach for point mutation detection based on electrochemiluminescence
2004
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor
2002 Standout
Characteristics of interferon induced tryptophan metabolism in human cells in vitro
1989
The PIT method: an automated in vitro technique for drug toxicity testing
1987
Regeneration beyond the glial scar
2004 Standout
Tubulin and Actin Topology during Zygote Formation of Saccharomyces cerevisiae
1987
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
1988 Standout
Sirolimus for Kaposi's Sarcoma in Renal-Transplant Recipients
2005 Standout
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Reduced levels of XPA, ERCC1 and XPF DNA repair proteins in testis tumor cell lines
2004
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
1990 Standout
A New Monoclonal Antibody (A78-G/A7) to the Thomsen—Friedenreich Pan-Tumor Antigen
1995
AID-deficient Bcl-xL transgenic mice develop delayed atypical plasma cell tumors with unusual Ig/Myc chromosomal rearrangements
2007 StandoutNobel
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
1983 StandoutNature
Small GTP-Binding Proteins
2001 Standout
Linkage of prion protein and scrapie incubation time genes
1986 StandoutNobel
[1] New bacteriophage lambda vectors with positive selection for cloned insects
1983 StandoutNobel
Reactivity of lymphocytes from normal persons on cultured tumor cells.
1973
Differences in the Peritoneal Response to Pristane in BALB/cAnPt and BALB/cJ Mice
1985
Cyclosporine induces cancer progression by a cell-autonomous mechanism
1999 Nature
Calculated Absorption and Scattering Properties of Gold Nanoparticles of Different Size, Shape, and Composition: Applications in Biological Imaging and Biomedicine
2006 Standout
E-cadherin gene mutations in human gastric carcinomacell lines.
1994
Extinction of the HPV18 upstream regulatory region in cervical carcinoma cells after fusion with non-tumorigenic human keratinocytes under non-selective conditions.
1991 StandoutNobel
H-2 Mutations: Their Genetics and Effect on Immune Functions
1978
Ectopic Expression of the Serotonin 1c Receptor and the Triggering of Malignant Transformation
1989 StandoutScienceNobel
Sweetening the Pot: Adding Glycosylation to the Biomarker Discovery Equation
2009
Inhibition of T-lymphocyte-mediated tumor-specific lysis by alloantisera directed against the H-2 serological specificities of the tumor
1975 StandoutNobel
The effect of particle design on cellular internalization pathways
2008 Standout
Heat tolerance in plants: An overview
2007 Standout
A cellular oncogene (c-Ki-ras) is amplified, overexpressed, and located within karyotypic abnormalities in mouse adrenocortical tumour cells
1983 StandoutNatureNobel
Tetrahydrobiopterin biosynthetic activities in human macrophages, fibroblasts, THP-1, and T 24 cells. GTP-cyclohydrolase I is stimulated by interferon-gamma, and 6-pyruvoyl tetrahydropterin synthase and sepiapterin reductase are constitutively present.
1990
Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour
1983 StandoutNatureNobel
Monoclonal anti-cytokeratin antibody from a hybridoma clone generated by electrofusion
1985
Interferon as a mediator of human lymphocyte suppression.
1980
Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
1982 Standout
Growth Factors and Cancer
1991 StandoutScience
The Molecular Genetics of Cancer
1987 StandoutScienceNobel
Prognostic Significance of a Novel Hypoxia-Regulated Marker, Carbonic Anhydrase IX, in Invasive Breast Carcinoma
2001 StandoutNobel
T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB- and Harvey-MSV transforming genes
1982 Nature
The Rapid Elimination of Allogeneic Lymphocytes: Relationship to Established Mechanisms of Immunity and to Lymphocyte Traffic
1983
Electrogenerated Chemiluminescence and Its Biorelated Applications
2008 Standout
Expression of CXC Chemokine Ligand 10 from the Mouse Hepatitis Virus Genome Results in Protection from Viral-Induced Neurological and Liver Disease
2007 StandoutNobel
Effect of Interferon-α1 from E. coli on Some Cell Functions
1980 StandoutScienceNobel
Radioimmunoassay of the cellular protein p53 in mouse and human cell lines.
1982
A genetic analysis of natural resistance to nonsyngeneic cells: The role of H-2
1984
Cell-Mediated Immunity to Tumor Cells
1974
Surface markers on human b and t lymphocytes. VI. Cytotoxicity against cell lines as a functional marker for lymphocyte subpopulations
1975
The heat shock response is involved in thermotolerance in suspension-cultured apple fruit cells
2002
Oncogenes in solid human tumours
1982 Nature
Three-dimensional analysis of morphogenesis induced by mating pheromone α factor in saccharomyces cerevisiae
1989 StandoutNobel
Isolation and preliminary characterization of a human transforming gene from T24 bladder carcinoma cells
1982 Nature
Parallel induction of tetrahydrobiopterin biosynthesis and indoleamine 2,3-dioxygenase activity in human cells and cell lines by interferon-γ
1989
Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
1986 StandoutNature
High Km glucose-phosphorylating (glucokinase) activities in a range of tumor cell lines and inhibition of rates of tumor growth by the specific enzyme inhibitor mannoheptulose.
1995
Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harvey-ras oncogene
1983 Nature
Chemical Glycoproteomics
2016 StandoutNobel
Glyco-seek: Ultrasensitive Detection of Protein-Specific Glycosylation by Proximity Ligation Polymerase Chain Reaction
2016 StandoutNobel
Works of V. Viklický being referenced
Expression of vimentin and glial fibrillary acidic protein in human developing spinal cord
1989
Changes of MAP2 phosphorylation during brain development.
1995
Immunological discrimination of β-tubulin isoforms in developing mouse brain. Post-translational modification of non-class-III β-tubulins
1992
Detection of blood group A antigen expression in human colon cancer using monoclonal antibodies with different specificities.
1989
Heat stress affects the organization of microtubules and cell division in Nicotiana tabacum cells
1997
Cellular immunity to renal carcinomas in man
1971
ROLE OF THE H‐2 COMPLEX IN THE HOMING AFFINITY OF INJECTED LYMPHOID CELLS TO THE HOST'S LYMPH NODES
1979
Murine Monoclonal Antibodies to Human A Erythrocytes: Differential Reactivity with N‐acetyl‐D‐galactosamine
1987
Neoformation of Lymphatics in the Mouse Omentum
1979
An attempted analysis of interstrain differences in the lymphoid system: strains B10, B10.A and A [proceedings].
1976
Established cell line of urinary bladder carcinoma (T24) containing tumour‐specific antigen
1973
Production and characterization of a monoclonal antitubulin antibody
1982